Modeling the dynamics and composition of T-cell receptor repertoires in post-acute sequelae of COVID-19 (PASC)
Project Number5R03AI175977-02
Former Number1R03AI175977-01
Contact PI/Project LeaderHADLOCK, JENNIFER
Awardee OrganizationINSTITUTE FOR SYSTEMS BIOLOGY
Description
Abstract Text
Project Summary
Post-acute sequelae of COVID-19 (PASC), colloquially known as longcovid, has been reported
in 31%-69% of COVID-19 patients. The prevalence of PASC among patients, even those with
mild infection, and those with prior vaccination, underscores the importance of principled
approaches for uncovering and addressing the cause of these issues. We propose to conduct a
detailed analysis of the immune repertoire dynamics of PASC patients and compare them to
both COVID-19 patients without PASC, and healthy individuals. These will be secondary
analyses, conducted on existing data from a previous study with the Institute of Systems Biology
and Swedish Health Services, which includes longitudinal deep immunophenotyping with single
cell and plasma multiomics, repertoire sequencing, electronic health records, viremia
measurements, and antibody titers for 209 COVID-19 patients. In Aim 1, we will conduct
inference, analysis, and comparison of T-cell receptor repertoire dynamics in PASC. Using
interpretable statistical, biophysical, and machine learning approaches, we will conduct a
detailed analysis of T-cell repertoires aimed at finding PASC specific clonotypes and their
corresponding receptor features. This involves building cohort specific models of thymic
selection, examining how these models differ between cohorts and over time, inferring the
dynamics of repertoire size, sharing and diversity, and uncovering the receptor features which
drive these differences. In Aim 2, we will develop new methods for the integration of T-cell
repertoire and single cell dynamics. The existing breadth of multiomics data allows us to explore
new methodologies for integrating different modalities of longitudinal data. For T-cell repertoires
in particular, we plan to extend existing models of thymic selection to include gene expression of
relevant T-cell specific genes and to study how the expansion and contraction of clonotypes
affects the dynamics of T-cells in gene expression space. By using interpretable biophysical and
machine learning methods, we can construct generative models of TCRs including gene
expression values and study how these distributions change in time. Results have strong
potential to accelerate our understanding of the etiology of immune-based PASC responses,
which is essential for prioritizing potential therapeutic targets for prevention and treatment.
Further, results will advance methods for future research across a wide range of infectious
diseases and immune-mediated medical conditions.
Public Health Relevance Statement
Narrative
Using secondary data from previous studies, we will conduct a detailed analysis of immune
repertoire dynamics in patients with post-acute sequelae of COVID-19 (PASC), as compared
with patients with a history of COVID-19 without PASC, and with healthy individuals. We will
build cohort-specific models of thymic selection, examining how these models differ between
cohorts and over time, inferring the dynamics of repertoire size, sharing and diversity, and
uncovering the receptor features which drive these differences. In addition, we will develop new
methods for the integration of T-cell repertoire and single cell dynamics, which will be of benefit
for future research across a wide range of infectious diseases and immune-mediated medical
conditions.
NIH Spending Category
No NIH Spending Category available.
Project Terms
2019-nCoVAccelerationAddressAffectAntibody titer measurementBenchmarkingBiological ModelsBiophysicsCOVID-19COVID-19 pandemicCOVID-19 patientCellsCommunicable DiseasesDataDedicationsElectronic Health RecordEtiologyFutureGene ExpressionGenesGenetic TranscriptionHealth ServicesImmuneImmunologyImmunophenotypingIndividualInfectionInterventionLongCOVIDMachine LearningMeasurementMediatingMedicalMethodologyMethodsModalityModelingMultiomic DataNatureObservational StudyPatientsPlasmaPlayPost-Acute Sequelae of SARS-CoV-2 InfectionPrevalencePreventionRecording of previous eventsRecoveryReportingRoleSARS-CoV-2 infectionScientistSeverity of illnessSigns and SymptomsSymptomsSystems BiologyT-LymphocyteT-cell receptor repertoireThymus GlandTimeVaccinationVaccinesVariantViralViremiaVirusWorkacute infectionadaptive immunitycohortcomorbiditygenerative modelsmachine learning methodmultiple omicspandemic diseasepersistent symptomreceptorresponsesecondary analysissevere COVID-19therapeutic targettoolvaccine development
National Institute of Allergy and Infectious Diseases
CFDA Code
855
DUNS Number
135646524
UEI
SMK9PCMKXED6
Project Start Date
18-December-2023
Project End Date
31-October-2025
Budget Start Date
01-November-2024
Budget End Date
31-October-2025
Project Funding Information for 2025
Total Funding
$91,180
Direct Costs
$48,500
Indirect Costs
$42,680
Year
Funding IC
FY Total Cost by IC
2025
National Institute of Allergy and Infectious Diseases
$91,180
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5R03AI175977-02
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R03AI175977-02
Patents
No Patents information available for 5R03AI175977-02
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R03AI175977-02
Clinical Studies
No Clinical Studies information available for 5R03AI175977-02
News and More
Related News Releases
No news release information available for 5R03AI175977-02
History
No Historical information available for 5R03AI175977-02
Similar Projects
No Similar Projects information available for 5R03AI175977-02